Madrigal Pharmaceuticals develops treatments for MASH, a serious liver disease, and sells its approved medicine Rezdiffra. It last closed at $379.10 on Nov 20, down 4.45% on the day. The next earnings report for MDGL is expected around Thu, Feb 18, 2027. For the quarter ended Sep 2026, MDGL reported EPS of $1.83 on revenue of $431.3M, with revenue up 50.1% from a year ago. Over its last 8 reports the stock moved an average of 8.7% the session after earnings. Over the last 12 months MDGL insiders bought $35.0M of stock on the open market and sold $69.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is MDGL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MDGL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MDGLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MDGL · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 10% below its 20 day and 22% below its 50 day average. It is 30% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the Pivot S1 at $371.52, and the nearest resistance the Pivot at $385.47.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 5.6%/day
Key levels
$615.0052 week high+62.2%
$496.53100 day average+31.0%
$494.08200 day average+30.3%
$462.3350 day average+22.0%
$443.30Swing high (Nov 10)+16.9%
$418.4820 day average+10.4%
$393.05Pivot R1+3.7%
$385.47Pivot+1.7%
$379.10Last close
$371.52Pivot S1−2.0%
$353.5452 week low−6.7%
$353.54Swing low (Nov 4)−6.7%
Indicators
RSI (14)
26.18
Oversold below 30
Oversold
MACD
-16.84
Below its signal line
Bearish
Stochastic
29.2
Middle of its range
Neutral
ADX (14)
20.9
Weak trend
Williams %R
-80.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-155.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.1%
Change over 10 sessions
Bearish
ATR (14)
$21.12
Typical daily range, 5.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 12.3%/day
Key levels
$615.0052 week high+62.2%
$496.53100 day average+31.0%
$494.08200 day average+30.3%
$462.3350 day average+22.0%
$443.30Swing high (Nov 10)+16.9%
$418.4820 day average+10.4%
$393.05Pivot R1+3.7%
$385.47Pivot+1.7%
$379.10Last close
$371.52Pivot S1−2.0%
$353.5452 week low−6.7%
$353.54Swing low (Nov 4)−6.7%
Indicators
RSI (14)
31.60
Weak, oversold below 30
Neutral
MACD
-25.33
Below its signal line
Bearish
Stochastic
24.4
Middle of its range
Neutral
ADX (14)
25.9
Trending down
Williams %R
-87.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-163.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.1%
Change over 10 sessions
Bearish
ATR (14)
$46.79
Typical daily range, 12.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for MDGL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MDGL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow MDGL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MDGLHow many large options trades hit MDGL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MDGL in the last 90 days.
From SEC Form 4 filings by MDGL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MDGL is in one of them and how their past MDGL trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company based in West Conshohocken, Pennsylvania. It focuses on treatments for MASH, a serious liver disease that can lead to cirrhosis, liver failure and liver cancer. Its main product, Rezdiffra, is an oral medicine taken once a day for adults with moderate to advanced liver scarring who do not have cirrhosis. The company sells Rezdiffra to patients and healthcare providers in the United States and Germany, and it is developing other candidates for the disease.